Medical Condition News

RSS

Researchers find new method to treat severe asthma

Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat severe asthma.

23 May 2018

Patients with low-back pain benefit from early physical therapy

Patients with low-back pain are better off seeing a physical therapist first, according to a study of 150,000 insurance claims.

23 May 2018

Study: Subtle hearing deficits can change the brains of young people

Cranking up your headphones or scrambling for a front-row spot at rock shows could be damaging more than your hearing.

23 May 2018

Slower rates of stimulation may be more effective in brain therapy, suggests research

One of the promising non-invasive brain therapeutic methods is the repetitive transcranial magnetic stimulation. During such a procedure, a magnetic coil is placed near the head of the patient and a magnetic pulse is transmitted to a specific damaged region of the brain.

23 May 2018

Schizophrenics' blood samples feature genetic material from more types of microorganisms

The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found.

22 May 2018

Celgene to share new and updated data around novel hematological therapies

Celgene Corporation today announced that data from a broad range of early and late stage studies evaluating Celgene investigational agents and investigational uses of marketed products will be presented at the 23rd European Hematology Association annual meeting in Stockholm, Sweden, from June 14-17, 2018.

22 May 2018

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica, Inc., a private biopharmaceutical company focused on developing innovative ophthalmology therapies, today announced that the Company has dosed the first patient in a Phase 1/2 dose-ranging clinical trial of PAN-90806, a once-daily topical eye drop formulation of a small-molecule anti-vascular endothelial growth factor (anti-VEGF) for the treatment of neovascular eye diseases.

22 May 2018

Researcher develops nanoparticle-based tags to detect viruses and cancer with high sensitivity

How can we detect cancer and viruses with high sensitivity? Physical chemist Laura Fabris - an associate professor in the Materials Science and Engineering Department at Rutgers, the State University of New Jersey, and principal investigator of the Fabris NanoBio Group - is addressing this very question.

22 May 2018

Specific patterns of fat distribution linked to metabolic disease, shows study

Specific patterns of fat distribution are linked to the presence of Coronary Heart Disease and Type 2 Diabetes, according to a new study published in Obesity.

22 May 2018

Researchers discover link between tuberculosis and Parkinson's disease

The mechanism our immune cells use to clear bacterial infections like tuberculosis (TB) might also be implicated in Parkinson's disease, according to a new collaborative study led by the Francis Crick Institute, Newcastle University and GSK.

22 May 2018

Study: Lifetime risks of developing Alzheimer's dementia vary by age, gender

Lifetime risks of developing Alzheimer's disease dementia vary considerably by age, gender and whether any signs or symptoms of dementia are present, according to a new study published online by Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

22 May 2018

New tool predicts the lifetime risk of Alzheimer’s

A new study has shown that the risk of Alzheimer’s disease significantly varies depending on age, gender and the presence of any signs or symptoms of dementia.

22 May 2018

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

An investigational new drug offers hope of relief for celiac disease patients who are inadvertently exposed to gluten while on a gluten-free diet.

22 May 2018

Researchers to test two-pronged approach in humans to treat advanced colorectal cancer

For the first time in humans, researchers will test a two-pronged approach to treat advanced stage colorectal cancer, potentially increasing life expectancy.

22 May 2018

Ingesting blue dye tablet during colonoscopy aids in detecting difficult-to-see polyps

Ingestion of a blue dye tablet during bowel prep for colonoscopy could be a significant advance in the early detection of colorectal cancer.

22 May 2018

Research team uncovers new information that more accurately explains formation of tumors

A collaborative research team has uncovered new information that more accurately explains how cancerous tumors grow within the body.

22 May 2018

Study: Medical centers more willing to perform lung transplants for severe alcoholic hepatitis patients

Increasingly, liver transplant centers are changing a long-standing practice of delaying potentially life-saving liver transplantation for patients with severe alcoholic hepatitis until after they stopped drinking alcohol for six months, according to a new study scheduled for presentation at Digestive Disease Week® (DDW) 2018.

22 May 2018

PCI along with prescribed drugs better than medication alone for treating for people with heart disease

A non-surgical procedure, called percutaneous coronary intervention, along with prescribed medication, is better than medication alone as initial treatment for people who have the most common form of heart disease, suggests an analysis of an international clinical trial co-led by St. Michael's Hospital.

22 May 2018

Study: Most people with preclinical signs of Alzheimer's disease may not develop dementia

During the past decade, researchers have identified new ways to detect the earliest biological signs of Alzheimer's disease.

22 May 2018

ToolGen's CRISPR/Cas9 gene editing platform improves T-cell anti-tumor activity in mouse model

ToolGen, Inc., a biotechnology company specializing in genome editing, today announced data demonstrating that blocking a molecular pathway that down-regulates T-cell activity with the Company’s CRISPR/Cas9 gene editing platform results in increased T-cell receptor signaling, in vitro, and in improved anti-tumor activity when tested against in a mouse glioblastoma tumor model.

22 May 2018

Medical Condition News

Researchers find new method to treat severe asthma

Patients with low-back pain benefit from early physical therapy

Study: Subtle hearing deficits can change the brains of young people

Slower rates of stimulation may be more effective in brain therapy, suggests research

Schizophrenics' blood samples feature genetic material from more types of microorganisms

Celgene to share new and updated data around novel hematological therapies

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

Researcher develops nanoparticle-based tags to detect viruses and cancer with high sensitivity

Specific patterns of fat distribution linked to metabolic disease, shows study

Researchers discover link between tuberculosis and Parkinson's disease

Study: Lifetime risks of developing Alzheimer's dementia vary by age, gender

New tool predicts the lifetime risk of Alzheimer’s

Investigational drug offers hope of relief for celiac disease patients exposed to gluten

Researchers to test two-pronged approach in humans to treat advanced colorectal cancer

Ingesting blue dye tablet during colonoscopy aids in detecting difficult-to-see polyps

Research team uncovers new information that more accurately explains formation of tumors

Study: Medical centers more willing to perform lung transplants for severe alcoholic hepatitis patients

PCI along with prescribed drugs better than medication alone for treating for people with heart disease

Study: Most people with preclinical signs of Alzheimer's disease may not develop dementia

ToolGen's CRISPR/Cas9 gene editing platform improves T-cell anti-tumor activity in mouse model

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News